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Abstract A novel Drosophila adenylyl cyclase (AC) was 
identified by PCR using degenerate primers specific for the 
known metazoan ACs. The full-length cDNA predicts a protein 
displaying significant sequence homology with mammalian Type 
IX AC (AC9). The abundance and size of the message for the 
Drosophila AC9 homolog (DAC9) changes through development. 
Biochemical analysis of DAC9 confirms it encodes a functional 
enzyme which can be activated by forskolin or G protein. 
Together with the Drosophila Type I AC homolog encoded by the 
learning and memory gene, rutabaga, the molecular identifica-
tion of DAC9 demonstrates there is a family of Drosophila AC 
isoforms reflecting at least part of the diversity of mammalian 
AC isoforms. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
In mammals , adenylyl cyclase (AC), the enzyme responsible 
for generating the second messenger cAMP, is encoded by a 
family of at least nine genes. These mammalian A C isoforms 
possess a conserved structure comprised of two sets of six 
t ransmembrane spans with each set followed by a distinct 
but homologous catalytic domain [1]. The two catalytic do-
mains, termed C ] a and C 2 a , are both necessary and sufficient 
for enzymatic activity [2]. Differences in tissue distribution 
and modes of regulation imply that each isoform plays a dis-
tinct role in c A M P production. For certain isoforms, specific 
functions have been predicted from their individual biochem-
ical properties [1], restricted localization [3,4], or expression 
patterns in different physiological states [5-7] or following 
pharmacological treatments [8-10]. However, only Type I 
A C (AC1) has been definitively assigned a specific physiolog-
ical role. Molecular genetic analysis in Drosophila melanogas-
ter revealed the AC1 ortholog is encoded by the learning and 
memory rutabaga gene [11,12]. Functional conservation of 
mammal ian AC1 was later confirmed by knockout experi-
ments in mouse [13]. 
A wide array of powerful genetic tools and an extensive list 
of molecularly uncharacterized mutat ions make Drosophila an 
excellent system to investigate gene functions. Specifically for 
the study of ACs, the fruit fly appears to be a valid indicator 
of mammalian physiology; the only characterized Drosophila 
A C is structurally, biochemically and functionally conserved 
with its mammalian ortholog A C 1 . However, for Drosophila 
to be a relevant model system for characterizing mammalian 
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ACs, it must display the diversity of A C isoforms present in 
mammals . We now describe the cloning of a second Droso-
phila A C displaying significant homology to a specific mam-
malian isoform. In addition to indicating that c A M P produc-
tion in Drosophila is accomplished by multiple A C isozymes, 
the evolutionary conservation of primary structure of at least 
two A C isoforms in Drosophila, the one described here and 
the previously characterized Rutabaga AC, suggest there is 
conservation of specific functions between fly and mammalian 
A C isozymes. 
2. Materials and methods 
2.1. Amplification of a novel Drosophila AC 
A cDNA fragment was amplified by Polymerase Chain Reaction 
(PCR) using degenerate oligonucleotide primers [14] designed to rec-
ognize the conserved regions within the second intracellular catalytic 
domain of mammalian ACs (LRL87 for the amino acid sequence 
KIKT(I/V)G and LRL88 for the amino acid sequence WG(N/K7 
D/E)TVN). Briefly, first-strand cDNA was prepared from 1 ug of 
D. melanogaster adult poly(A)+ RNA (Clontech) using Superscript 
Moloney murine leukemia virus reverse transcriptase (Life Technol-
ogies, Inc.). Approximately 2% of the resultant first-strand cDNA was 
subjected to PCR amplification in a total volume of 25 ul under stand-
ard conditions (Perkin Elmer). After denaturation at 94°C for 5 min, 
reactions were cycled 30 times for 1 min at 94°C, 30 s at 60°C and 30 s 
at 72°C followed by final extension at 72°C for 10 min. Products were 
separated on 1% agarose or 2% TreviGel (Trevigen) agarose gels, and 
a band of the appropriate size (270 base pairs) was excised and TA 
cloned into pCR-II (Invitrogen). The subcloned fragment was se-
quenced by chain termination using Sequenase-2 (Amersham). Clone 
AR7.1 corresponded to a novel Drosophila AC-like sequence. 
2.2. cDNA library screening 
Random-prime labeled AR7.1 was used to screen approximately 
106 clones of a Drosophila adult cDNA library constructed in our 
laboratory using the ZAP Express cDNA synthesis kit (Stratagene). 
Five positive clones were recovered. The longest clone (AR7.1 #3) was 
3.1 kb and encoded only a portion of the putative Drosophila AC. Its 
predicted open reading frame was homologous to AC sequences ex-
tending N-terminally from the second set of transmembrane domains 
through its presumptive C-terminus. The 5'-most sequences from the 
longest clone were used to screen a randomly primed Drosophila head 
cDNA library cloned into ^.-gtl 1 kindly provided by Dr. Mike Forte 
[15]. The longest clones from this screen extended the putative open 
reading frame further, predicting a potential AC with 12 membrane-
spanning domains, but it did not appear to correspond to the full-
length cDNA. The final 5'-end sequence was obtained after an addi-
tional round of screening the random-primed Drosophila head library 
(Fig. 1). The final, full-length cDNA was reconstructed in pBluescript 
KS (Stratagene). 
The full-length cDNA was sequenced on both strands by Rocke-
feller University or Cornell University Sequencing Cores using fluo-
rescent dye terminator thermal cycle sequencing (PE-Applied Biosys-
tems). 
2.3. Northern blotting 
Commercially obtained (Clontech) Drosophila Embryonic, Larval 
and Adult poly(A)+ RNA (2.5 ug each) were separated on a 1% 
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denaturing agarose gel and transferred to nylon membrane [16]. The 
4.2-kb XhoI-XmnI fragment of AR7.1 (Fig. 1) was labeled by random 
priming (Amersham). The filter was hybridized with probe overnight 
at 60°C in 50% formamide, 5X Denhardt's, 5XSSPE, 5% SDS, 
200 ug/ml ssDNA, washed in 2XSSC, 0.1% SDS+O.lxSSC, 0.1% 
SDS at 65°C and exposed to X-ray film (Kodak) with intensifying 
screen for the indicated times. 
2.4. Expression and assay of Drosophila ACs 
The AR7.1 putative AC was heterologously expressed in mamma-
lian cells using the cytomegalovirus promoter/enhancer of pRK5. Hu-
man embryonic kidney cells (HEK293) were transiently transfected 
using Lipofectamine (GIBCO BRL) with Drosophila AR7.1 cDNA 
or pRK5 vector with or without human luteinizing hormone receptor 
(LHR) subcloned into pKNH expression vector [17]. For cAMP ac-
cumulation assays, two days after transfection, cells were labeled for 
an additional 24 h with [3H]adenine (2 uCi/ml) and assayed in the 
absence or presence of 1 u,g/ml human P-chorionic gonadotropin 
(hCG) (Sigma). The level of intracellular cAMP was measured and 
expressed as the ratio of [3H]cAMP to total adenine nucleotides as 
described previously [18]. AC activity in crude lysates was determined 
72 h after transfection as described previously [12]. Data points rep-
resent triplicate assays and are reported as means ± S.D. 
2.5. Isolation of PI clones 
A Drosophila PI genomic library (Genome Systems) densely plated 
on filters was screened by hybridization with the 4.2-kb XhoI-Xmnl 
fragment corresponding to the coding sequence of AR7.1 cDNA (Fig. 
1). Hybridization to positive clones was confirmed by Southern hy-
bridization. Map positions of positive PI clones were determined by 
Berkeley Drosophila Genome Project and were obtained via internet 
access (http ://fruitfly.berkeley.edu/). 
3. Results 
3.1. Cloning a new Drosophila adenylyl cyclase 
A novel AC-like sequence, AR7.1, was identified by PCR 
on Drosophila adult cDNA using degenerate primers designed 
to recognize C2a domain sequences conserved in all previously 
described mammalian ACs and Drosophila Rutabaga AC. Us-
ing this AR7.1 PCR product as probe, five independent clones 
falling into two overlapping classes were isolated from a Dro-
sophila adult oligo dT-primed cDNA library. In two of the 
five clones (AR 7.1 #2 and AR 7.1 #3 in Fig. 1), the site of 
poly-A addition was 600 nucleotides upstream compared to 
the other 3 clones. All five clones contained typical polyade-
nylation signal sequences (AATAAA) 25 nucleotides up-
stream from their respective poly-A+ addition sites. These 
2 classes of cDNAs appear to reflect differential polyadenyl-
ation usage in vivo (see below and Fig. 3). Two successive 
screenings of a randomly primed Drosophila head cDNA li-
brary resulted in the isolation of an additional 3 overlapping 
clones which were used to reconstruct the full-length AR7.1 
cDNA (Fig. 1). This cDNA contained a single large open 
reading frame consisting of 1708 amino acids. The hydropho-
bicity profile of the presumptive protein, calculated using the 
Kyte and Doolittle algorithm in the Protean sequence analysis 
program (DNASTAR), predicts the postulated structure for 
all cloned metazoan ACs (Fig. 2A). 
According to BLAST sequence analysis, the predicted pro-
tein sequence of Drosophila AR7.1 was most closely related to 
mouse AC9. Database searches revealed two other potential 
AC9 orthologs. A recently described Xenopus laevis oocyte 
AC [19] and a putative gene product in Caenorhabditis elegans 
detected by the Sanger Centre Genome Project (http:// 
www.sanger.ac.uk/Projects/C_elegans/). Comparison of Dro-
sophila AR7.1 with these two newly described ACs, the nine 
known mammalian ACs and Drosophila Rutabaga AC using 
the Clustal multiple sequence alignment algorithm within 
Megalign program (DNASTAR) suggests that AR7.1, the 
X. laevis AC (xlAC), the C. elegans AC (ceAC), and mouse 
AC9 define an interspecies subfamily comprised of apparent 
AC9 orthologs (Fig. 2B). Based on these sequence similarities, 
we refer to the Drosophila AR7.1 clone as DAC9. 
Genomic Southern hybridization data demonstrated that 
DAC9 is present in the D. melanogaster Canton S genome 
as single-copy gene (data not shown), and isolation of a Dro-
sophila PI library clone indicates that the DAC9 locus maps 
to position 35C7-9. 
3.2. Expression of DAC9 
DAC9 mRNA expression, determined by Northern Blot 
analysis using a coding sequence-specific probe, varied in 
abundance and size through the Drosophila life cycle (Fig. 
3). An 8.9-kb DAC9 mRNA was expressed throughout devel-
opment and was the predominant species in embryos and 
adult flies. Adults also expressed an approximately equally 
abundant 7.5-kb message. The presence of two DAC9 
mRNA species in adult flies correlates with the diversity of 
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Fig. 1. cDNA clones corresponding to DAC9 D. melanogaster adenylyl cyclase. Overlapping clones corresponding to AR7.1 are shown sche-
matically. Light gray bars represent the 2 groups of clones isolated from the Drosophila adult cDNA library (clones AR7.1 #2 and #3) differing 
in their 3' ends, and dark gray bars represent clones isolated from the randomly primed Drosophila head cDNA library (clones AR7.1 #23, 
#31 and #3/5') [17]. The full-length open reading frame is represented as an open bar with restriction sites used in reconstruction indicated 
(Ncol, Kpnl and Nrul). The Xhol-Xmnl 4.2-kbp fragment was used as probe in Northern blot analysis and PI library screen. 
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Fig. 2. Deduced amino acid sequence of DAC9. (A) Calculated hydrophobicity profile of DAC9. Twelve predicted transmembrane spans are 
filled in and labeled TM 1-6 and TM 7-12. Regions corresponding to the conserved catalytic domains are labeled Cia and C2a and the variable 
domains are labeled Cib and C2b. The approximate size, in amino acids, is indicated above. (B) Alignment of predicted amino acid sequences 
of known Drosophila ACs with the 9 known mammalian ACs. Drosophila, Xenopus and C. elegans ACs are shown in bold. Previously pub-
lished AC sequences were as follows; ACl-bovine AC1 [25]; AC2-rat AC2 [26]; AC3-rat AC3 [3]; AC4-rat AC4 [27]; AC5-rat AC5 [28]; 
AC6-rat AC6 [28]; AC7-mouse AC7 [29]; AC8-rat AC8 [30]; AC9-mouse AC9 [22]; Rutabaga AC [12], Xenopus laevis oocytes AC-xlAC9 [19], 
C. elegans AC-ceAC9 (http://www.sanger.ac.uk/Projects/C_elegans/). 
3' ends among cDNA clones detected in the adult cDNA 
library; as described above, this very likely reflects alternative 
polyadenylation site utilization. Interestingly, the predomi-
nant mRNA in larvae was 7.2 kb. This larval-specific 7.2-kb 
DAC9 mRNA has not been further investigated but might 
imply a specific function for DAC9 during larval develop-
ment. 
3.3. Enzymatic activity of DAC9 
We first tested whether DAC9 protein had enzymatic activ-
ity in response to activated Gs protein in vivo. HEK293 cells 
were cotransfected with DAC9 and the Gs-coupled LH recep-
tor [17]. Treatment of cotransfected cells with hCG, a specific 
LH receptor agonist, induced cAMP production in DAC9 
expressing cells 4-fold over vector transfected cells (Fig. 4). 
These results confirm that this novel Drosophila cDNA en-
codes a functional AC and is capable of coupling to the en-
dogenous human Gs protein. 
The in vitro biochemical properties of DAC9 were then 
compared with those of its mammalian counterpart. Basal 
activities in crude lysates of HEK293 cells transfected with 
DAC9 exhibited less basal activity than murine AC9 lysates; 
however, the DAC9 responses to activated G protein and 
to forskolin were much more pronounced than those of 
its mammalian counterpart (Fig. 5A). Dose-dependent stimu-
lation of DAC9 activity was consistently greater than vector 
control at GTPyS concentrations as low as 0.5 uM (Fig. 5B) 
and forskolin concentrations as low as 5 \iM (Fig. 5D). In 
contrast to mammalian AC9, DAC9 is potently stimulated by 
forskolin. 
B 
4. Discussion 
The use of Drosophila as a genetic model for studying mam-
malian ACs is dependent upon it possessing a gene family of 
AC isoforms of similar extent and complexity as that found in 
DAC9 
8.9 kb 
7.5 kb 
7.2 kb 
rp49 
0.6 kb 
Fig. 3. Expression of DAC9 mRNA through development. 2.5 |ig 
of Drosophila embryonic (E), larval (L) and adult (A) poly(A)+ 
RNAs were hybridized to DAC9 (top) coding region-specific probe. 
As load control, the blot was probed with the ribosomal protein 49 
(rp 49) specific probe (bottom). Film exposure times were as follow 
30 h for DAC9 and 1 h for rp 49. The approximate sizes of each 
message were calculated in relation to a commercially available 
RNA ladders (Life Technologies). 
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Fig. 4. In vivo cAMP accumulation of DAC9. cAMP accumulation 
in HEK293 cells coexpressing DAC9 with LH receptor cDNA de-
termined in the absence (—hCG) or presence (+hCG) of human 
chorionic gonadotropin. Values correspond to the ratio of cAMP to 
total adenine nucleotides and represent means of triplicate assays 
with error bars indicating standard deviation. 
mammals. Residual cyclase activity in flies deficient for the 
only previously known Drosophila AC, Rutabaga AC 
[11,20], and distinct AC-like sequences detected in Drosophila 
genomic DNA [12,21], suggested the existence of additional 
AC isoforms in flies. However, there has so far been no direct 
demonstration of multiple AC isoforms in Drosophila nor an 
indication of their molecular nature. The additional Drosophi-
la AC gene described here confirms that cAMP synthesis in 
flies is accomplished by a family of AC isoforms showing 
significant structural homology to mammalian AC isozymes. 
DAC9 is highly homologous to mouse AC9 as well as to 
newly described isoforms from Xenopus and C. elegans. There 
is 55% amino acid identity between the catalytic domains of 
DAC9 and those of mouse AC9. The C. elegans isoform is 
similarly conserved, exhibiting 54% identity within its catalytic 
domains compared to mammalian AC9. This significant struc-
tural conservation of type 9 AC across evolution suggests it 
performs an important physiological function. Additionally, 
AC9 isoforms appear to be nearly ubiquitously expressed, 
also implying a fundamental biological role. Mammalian 
AC9 is widely expressed in adult mice [22], DAC9 is expressed 
throughout fly development, and Xenopus AC9 mRNA is 
abundant in oocytes but was not detected in early embryos 
[19]. Expression patterns of C. elegans AC9 or of Xenopus 
AC9 later in development are not yet known. 
DAC9 is the longest of the AC9 isoforms primarily due to 
its large Cib domain (Fig. 2A). This region does not appear to 
be required for Gs or forskolin responsiveness [2]; W.-J. Tang, 
personal communication) and might be involved in subcellular 
localization or have as yet undiscovered regulatory interac-
tions. 
Consistent with previous reports [22], heterologously ex-
Basal GTPyS FSK 
B 
Forskolin, \M 
Fig. 5. In vitro AC activity of DAC9 compared to mammalian 
AC9. (A) AC activity was measured in crude lysates prepared from 
HEK293 cells expressing vector alone (open bars) DAC9 (striped 
bars), or mouse AC9 (black bars) without any addition (basal), with 
100 |xM GTPyS or with 100 uM forskolin (FSK). AC activity in 
crude lystates of vector-transfected (open symbol) or DAC9-trans-
fected (filled symbol) HEK293 cells determined in the presence of 
increasing concentrations of (B) GTPyS or (C) forskolin. Values 
correspond to pmoles cAMP formed per min per mg protein and 
represent means of triplicate assays with error bars indicating stand-
ard deviations. 
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pressed murine AC9 exhibited high basal activity which was 
essentially insensitive to forskolin. In contrast, DAC9 basal 
activity was undetectable in transiently transfected HEK293 
cells but was significantly stimulated by forskolin. The phys-
iological significance of activation by the diterpene forskolin is 
not known, but this difference in responsiveness would be 
predicted from the amino acid sequences of murine AC9 
and DAC9. Two residues in AC9 C2a which differ from every 
other known member of the AC superfamily (residue 1082 in 
murine AC9 is tyrosine instead of the conserved leucine and 
residue 1112 is alanine instead of the conserved serine) appear 
to be involved in forskolin responsiveness. In particular, the 
Tyr1082 substitution is sufficient to abrogate forskolin respon-
siveness in AC9 (S.-Z. Yan, Z.-H. Huang, and W.-J. Tang, 
personal communication). Interestingly, the analogous resi-
dues in DAC9, Leu1407 and Ser1437, are conserved with the 
AC superfamily and correctly predict DAC9 should be for-
skolin responsive. 
There are many uncharacterized mutations corresponding 
to the genetic map position of DAC9, one in particular is a 
potentially interesting candidate. A female sterile mutation, 
midway, maps near 35C [23], and it has long been known 
that there is an important role for an AC in fly fertility [24]. 
We are currently pursuing an extensive genetic analysis of this 
and other genetic defects mapping to 35C to determine 
whether they are caused by mutation of DAC9. 
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